$SYN Synthetic Biologics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Synthetic Biologics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Synthetic Biologics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Synthetic Biologics, Inc. for free.
IRS Number: 133808303
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SYN
Company Address: 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE 20850
Phone number: (301) 417-4364
Former name: SHEFFIELD MEDICAL TECHNOLOGIES INC, date of change: 1994-06-06
Former name: SHEFFIELD PHARMACEUTICALS INC, date of change: 1997-07-30
Former name: PIPEX PHARMACEUTICALS, INC., date of change: 2006-12-14
Former name: ADEONA PHARMACEUTICALS, INC., date of change: 2008-10-27
Market Capitalization: $76.50M
Prev close: $0.85
Average Daily Volume: 1,195,250
Days Low: $0.82
Year Low: $0.73
Year High: $2.73
Synthetic Biologics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Buy | P | 0.49 | 50,000 | 24,595 | 100,000 | 50 K to 100 K (+100.00 %) |
| Dec 31 2020 | SYN | Synthetic Biologic ... | Wolf Jeffrey Alan | Director | Option Exercise | A | 0.42 | 150,000 | 62,550 | 150,000 | |
| Dec 31 2020 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Option Exercise | A | 0.42 | 450,000 | 187,650 | 450,000 | |
| Dec 31 2020 | SYN | Synthetic Biologic ... | MONAHAN JOHN J | Director | Option Exercise | A | 0.42 | 150,000 | 62,550 | 150,000 | |
| Dec 31 2020 | SYN | Synthetic Biologic ... | Kraws Jeffrey J | Director | Option Exercise | A | 0.42 | 150,000 | 62,550 | 150,000 | |
| Dec 06 2019 | SYN | Synthetic Biologic ... | Tarriff Scott | Director | Option Exercise | A | 0.42 | 250,000 | 104,500 | 250,000 | |
| Dec 06 2019 | SYN | Synthetic Biologic ... | Kraws Jeffrey J | Director | Option Exercise | A | 0.42 | 250,000 | 104,500 | 250,000 | |
| Dec 05 2019 | SYN | Synthetic Biologic ... | Wolf Jeffrey Alan | Director | Option Exercise | A | 0.42 | 250,000 | 104,500 | 250,000 | |
| Dec 05 2019 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Option Exercise | A | 0.42 | 450,000 | 188,100 | 450,000 | |
| Aug 26 2019 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Buy | P | 0.42 | 50,000 | 20,785 | 50,000 | 0 to 50 K |
| Apr 03 2019 | SYN | Synthetic Biologic ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.65 | 69,161 | 44,955 | 165,332 | 234.5 K to 165.3 K (-29.49 %) |
| Apr 03 2019 | SYN | Synthetic Biologic ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.65 | 26,080 | 16,952 | 62,342 | 88.4 K to 62.3 K (-29.49 %) |
| Apr 03 2019 | SYN | Synthetic Biologic ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.66 | 9,909 | 6,540 | 234,493 | 244.4 K to 234.5 K (-4.05 %) |
| Apr 03 2019 | SYN | Synthetic Biologic ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.66 | 3,737 | 2,466 | 88,422 | 92.2 K to 88.4 K (-4.05 %) |
| Apr 03 2019 | SYN | Synthetic Biologic ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.67 | 30,265 | 20,278 | 244,402 | 274.7 K to 244.4 K (-11.02 %) |